Page last updated: 2024-09-02

fingolimod hydrochloride and Enterobacteriaceae Infections

fingolimod hydrochloride has been researched along with Enterobacteriaceae Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hall, LJ; Hurley, G; MacSharry, J; Melgar, S; Murphy, CT; Nally, K; Quinlan, A; Shanahan, F	1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Enterobacteriaceae Infections

Article	Year
The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium. Infection and immunity, 2012, Volume: 80, Issue:8 Topics: Animals; Citrobacter rodentium; Enterobacteriaceae Infections; Female; Fingolimod Hydrochloride; Gene Expression Regulation; Immunity, Mucosal; Immunosuppressive Agents; Lymphopenia; Mice; Mice, Inbred Strains; Propylene Glycols; RNA, Messenger; Specific Pathogen-Free Organisms; Sphingosine	2012

Article

Year

The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.

Infection and immunity, 2012, Volume: 80, Issue:8

Topics: Animals; Citrobacter rodentium; Enterobacteriaceae Infections; Female; Fingolimod Hydrochloride; Gene Expression Regulation; Immunity, Mucosal; Immunosuppressive Agents; Lymphopenia; Mice; Mice, Inbred Strains; Propylene Glycols; RNA, Messenger; Specific Pathogen-Free Organisms; Sphingosine

2012